• The specific situation of the patient. Unless otherwise provided for by national regulations,
off-label use of medication should be limited to situations where it is in the patient's interest …

Clinically manifest cardiac involvement occurs in perhaps 5% of patients with sarcoidosis.
The 3 principal manifestations of cardiac sarcoidosis (CS) are conduction abnormalities …

This joint position paper illustrates the role and the correct use of echocardiography,
radionuclide imaging with 18F-fluorodeoxyglucose positron emission tomography …

Objectives: This study analyzed the accuracy of gadolinium-enhanced cardiovascular
magnetic resonance (CMR) for the diagnosis of cardiac sarcoidosis (CS). Background: The …

Sarcoidosis is a multisystem granulomatous disease of unknown etiology characterized by
noncaseating granulomas in involved organs. Organs involved with sarcoidosis include …

This retrospective study concerned 18 female and 23 male patients with cardiac sarcoidosis
(CS). The average age at CS diagnosis was 38 years. CS was observed in white (73% of …

Sarcoidosis is a chronic inflammatory disease of unknown etiology characterized by multi-
organ involvement. End-organ disease consists of granulomatous inflammation, which if left …

Sarcoidosis is an inflammatory granulomatous disease that can affect any organ. Up to one-
quarter of patients with systemic sarcoidosis may have evidence of cardiac involvement. The …

Sarcoidosis is a multisystemic granulomatous disease of unknown etiology that may involve
virtually any organ. Pulmonary involvement predominates, but sarcoidosis can involve …

Study objectives We aimed to determine cardiac involvement in patients with pulmonary
sarcoidosis (PS) followed up at two university medical centers in the Netherlands. Design …